Gamma Investing LLC Denali Therapeutics Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 2,248 shares of DNLI stock, worth $47,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,248
Previous 2,338
3.85%
Holding current value
$47,612
Previous $68.1 Million
32.73%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DNLI
# of Institutions
227Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Baillie Gifford & CO13.3MShares$283 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$237 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$227 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$168 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.84B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...